Dr. Patrizia Cavazzoni, Director of FDA's Center for Drug Evaluation and Research (CDER), will be joining the Alliance for a Stronger FDA in our annual budget series of webinars that come out following the President's Budget.
This Alliance webinar will host Dr. Cavazzoni to discuss the President’s Budget and the CDER components of that request and how it would contribute to fulfilling the Center’s mission.
Patrizia Cavazzoni, M.D., is the director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration. The Center’s mission is to ensure that safe, effective and high-quality drugs are available to the public. To achieve this, CDER regulates the medical products under its jurisdiction throughout their lifecycle, oversees the development of new and generic drugs, evaluates applications to determine whether drugs should be approved, monitors the safety of drugs after they are marketed, conducts research to advance regulatory science and takes enforcement actions to protect the public from harmful products. Dr. Cavazzoni joined the FDA in January 2018 as CDER’s Deputy Director for Operations where she has led several key initiatives on behalf of the organization. She also served as Acting Principal Deputy Commissioner of Food and Drugs from January 2019 to February 2019.
